Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 1, 2004, Pages 8-12

  Chang, Rong Kun ^a   Shojaei, Amir H ^a  

^a Shire Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG VEHICLE; EXCIPIENT; LABRASOL; LACTOSE; N [1 [2 CARBOXY 3 (N MESYLLYSYLAMINO)PROPYL] 1 CYCLOPENTANYLCARBONYL]TYROSINE; UK 81252; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLASSIFICATION; DRUG DISPOSITION; DRUG FORMULATION; DRUG STRUCTURE; IN VIVO STUDY; LIQUID; NONHUMAN; SINGLE DRUG DOSE; STOMACH EMPTYING;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DOGS; DRUG INTERACTIONS; EMULSIONS; EXCIPIENTS; MESYLATES; ORGANIC CHEMICALS; TYROSINE;

EID: 2442429537     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Norton, G.R., et al., Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects. American Journal of Hypertension, 1999. 12: p. 563-571.
2. Amidon, G., et al., A Theoretical Basis for a Biopharmaceutics Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability. Pharm Res, 1995. 12: p. 413-420.
3. Wang, Y., et al., A Double-Peak Phenomenon in the Pharmacokinetics of Alprazolam after Oral Administration. Drug Metabolism and Disposition, 1999. 27(8): p. 855-859.
4. Bressolle, F., et al., Double Weibull input function describes the complex absorption of sustained-release oral sodium valproate. J Pharm Sci, 1994. 83(10): p. 1461-1464.
5. Charman, W.N., et al., Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single and double peak phenomena in the plasma profiles. J Clin Pharmacol, 1993. 33: p. 1207-1213.
6. Lennernas, H. and C.-G. Regardh, Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading dose-dependent oral absorption and double peaks in the plasma concentration-time profile. Pharm Res, 1993. 10(6): p. 879-883.
7. Cook, C., et al., Pharmacokinetics of a novel antiarrhythmic drug, Actisomide. Pharm Res, 1993. 10(3): p. 427-433.
8. Mummaneni, V. and J.B. Dressman, Intestinal uptake of cimetidine and ranitidine in rats. Pharm Res, 1994. 11(11): p. 1599-1604.
9. Cooke, A., Control of gastric emtying and motility. Gastroenterology, 1975. 68(4): p. 804-816.
10. Lish, P., Some pharmacologic effects of dioctyl sodium sulfosuccinate on the gastrointestinal tract of the rat. Gastroenterology, 1961. 41: p. 580-584.
11. Necheles, H. and J. Sporn, Effect of detergents on gastric motility. American Journal of Gastroenterology, 1966. 46: p. 481-483.